Added to YB: 2025-03-11
Pitch date: 2025-03-08
STVN [neutral]
Stevanato Group S.p.A.
+0.56%
current return
Author Info
Best Anchor Stocks shares deep research on companies with long-term potential aThe Bear Cavend lower-than-average volatility. Sign up for the newsletter.
Company Info
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
Market Cap
$5.2B
Pitch Price
$21.18
Price Target
N/A
Dividend
0.28%
EV/EBITDA
20.28
P/E
37.31
EV/Sales
4.72
Sector
Life Sciences Tools and Services
Category
growth
More Information for a lower price
STVN (earnings update): Q4 beat, vial destocking over. 2024: Rev +2%, HVS +15%, OCF +48%. 2025 guide: Rev +5-8%, EBITDA margin +200bps to 25.5%. Capex high but customer-validated. Biologics driving HVS shift. FCF negative but improving. Long-term growth intact despite near-term headwinds.
Read full article (7 min)